GDP
IBB icon

Great Diamond Partners’s iShares Biotechnology ETF IBB Stock Holding History

Great Diamond Partners’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-160
Closed -$19K – 341
2019
Q4 		$19K Buy
+160
New +$17.9K 0.01% 489

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Great Diamond Partners's IBB Position: Q1 2020 in Review

Great Diamond Partners sold out of iShares Biotechnology ETF (IBB) in Q1 2020, closing a stake of 160 shares — an estimated $19K sold.

Great Diamond Partners first reported a position in IBB in Q4 2019 and held it in 1 quarter. The position peaked at $19K in Q4 2019. 668 funds tracked by Wall St. Rank hold IBB as of Q1 2020.

  • Great Diamond Partners reported no remaining iShares Biotechnology ETF position as of Q1 2020 after selling out during the quarter.
  • Great Diamond Partners sold 160 iShares Biotechnology ETF shares in Q1 2020, an estimated $19K.
  • Great Diamond Partners first reported a position in iShares Biotechnology ETF in Q4 2019 and held it in 1 quarter.
  • Great Diamond Partners's iShares Biotechnology ETF position peaked at $19K in Q4 2019.
  • 668 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2020.

Based on Great Diamond Partners's 13F filing for Q1 2020, filed 1 May 2020.